
Sign up to save your podcasts
Or
On this episode of ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum, Dr. Timothy Murray welcomes Michael J. Shapiro, MD, of Retina Consultants in Chicago, IL, who discusses the aggressive onset of familial exudative vitreoretinopathy (FEVR)–like vascular disease in a 3-year-old patient with mutations in LRP5 and TSPAN12 and a 16-year follow-up after laser ablation. Tune in for a discussion on mutational alterations associated with FEVR that suggest genetic testing is becoming the norm for atypical pediatric retinal diseases.
For more information, visit www.ASRS.org/JVRDForum.
Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS) offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care.
On this episode of ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum, Dr. Timothy Murray welcomes Michael J. Shapiro, MD, of Retina Consultants in Chicago, IL, who discusses the aggressive onset of familial exudative vitreoretinopathy (FEVR)–like vascular disease in a 3-year-old patient with mutations in LRP5 and TSPAN12 and a 16-year follow-up after laser ablation. Tune in for a discussion on mutational alterations associated with FEVR that suggest genetic testing is becoming the norm for atypical pediatric retinal diseases.
For more information, visit www.ASRS.org/JVRDForum.
Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS) offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care.
32 Listeners
98 Listeners
17 Listeners
5 Listeners
11 Listeners
4 Listeners
20 Listeners
10 Listeners
50 Listeners
10 Listeners
1 Listeners
18 Listeners
16 Listeners
0 Listeners
0 Listeners